Molecular Therapy: Nucleic Acids (Jun 2018)

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice

  • Yuan Xia,
  • Jin-Hui Tao,
  • Xuan Fang,
  • Nan Xiang,
  • Xiao-Juan Dai,
  • Li Jin,
  • Xiao-Mei Li,
  • Yi-Ping Wang,
  • Xiang-Pei Li

DOI
https://doi.org/10.1016/j.omtn.2018.02.010
Journal volume & issue
Vol. 11, no. C
pp. 284 – 291

Abstract

Read online

B cells are recognized as key participants in various autoimmune diseases, including systemic lupus erythematosus (SLE). Although sets of transcription factors and cytokines are known to regulate B cell differentiation, the roles of microRNAs are poorly understood. Our previous study proved that microRNA-326 (miR-326) was markedly upregulated in SLE patients; however, the biological function of miR-326 during SLE pathogenesis remained unknown. In this study, we found that miR-326 overexpression in MRL/lpr mice led to B cell hyperactivity and severe SLE. Moreover, E26 transformation-specific-1 (Ets-1), a negative regulator of B cell differentiation, was identified as a target of miR-326. Therefore, a novel mechanism has been found in which the elevated miR-326 in B cells of SLE promotes plasmablast development and antibody production through downregulation of Ets-1.

Keywords